Health Care & Life Sciences » Pharmaceuticals | Haisco Pharmaceutical Group Co. Ltd.

Haisco Pharmaceutical Group Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
978
1,194
1,197
1,413
1,826
3,373
Cost of Goods Sold (COGS) incl. D&A
286
388
424
406
696
1,542
Gross Income
692
806
773
1,007
1,130
1,831
SG&A Expense
270
413
428
742
1,020
1,663
EBIT
417
387
338
-
109
163
Non Operating Income/Expense
-
3
3
1
110
167
Interest Expense
3
12
15
19
26
21
Pretax Income
567
504
415
483
258
335
Income Tax
50
54
43
47
30
5
Equity in Affiliates
-
1
-
2
1
12
Consolidated Net Income
519
451
372
436
229
318
Net Income
519
451
372
443
238
333
Net Income After Extraordinaries
519
451
372
443
238
333
Net Income Available to Common
519
451
372
443
238
333
EPS (Basic)
0.48
0.42
0.35
0.41
0.22
0.31
Basic Shares Outstanding
1,080
1,080
1,075
1,070
1,070
1,070
EPS (Diluted)
0.48
0.42
0.35
0.41
0.22
0.31
Diluted Shares Outstanding
1,080
1,080
1,075
1,070
1,070
1,070
EBITDA
443
430
391
323
173
237
Other Operating Expense
5
5
7
3
1
5
Non-Operating Interest Income
46
78
82
88
65
48
Minority Interest Expense
-
-
-
7
8
16

About Haisco Pharmaceutical Group Co.

View Profile
Address
17 Sanxiang Avenue
Shannan Tibet 856000
China
Employees -
Website http://www.haisco.com
Updated 07/08/2019
Haisco Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical drugs and medical equipment. Its products include active pharmaceutical ingredients and generic drugs. The company was founded on August 26, 2005 and is headquartered in Shannan, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.